Increasing Incidence of Early Onset Locally Advanced Colorectal Cancer: Does Adjuvant Treatment Has a Clinical Improvement?

Authors

  • Budhi Ida Bagus Department of Surgery, Sebelas Maret University, Indonesia

DOI:

https://doi.org/10.29103/micohedmed.v2i.1203

Keywords:

early onset, colorectal cancer, adjuvant treatment

Abstract

The global prevalence of early-onset colorectal cancer (EO-CRC) has exhibited a notable upward trend, thereby emerging as a significant concern within the realm of public health. The clinical, genetic, molecular, and histological characteristics of this condition indicate that it may be a separate entity, exhibiting a higher level of aggression. Nevertheless, it appears that both genetic and environmental risk factors play a role in the observed epidemiological change in the incidence of colorectal cancer (CRC). Further evidence is required to elucidate the etiology of EO-CRC and to formulate effective screening and management approaches. The management of colorectal cancer in young adults is an unmet clinical need, given that the disease may result in the greatest loss of years of life in this demographic upon diagnosis. The incidence of colorectal cancer (CRC) in people under 50 has been rising annually since early 1990 at a rate of 2%. Since the frequency of CRC has been declining overall, the rise in the disease's incidence among young adults is especially concerning. The primary tumor of early-onset colorectal cancer (CRC) is located on the left side of the colon and is associated with poorer cell differentiation, a higher prevalence of signet ring cell histology, and an advanced stage at diagnosis. 20% of patients have familial colorectal cancer (CRC), and about 30% of patients have tumors containing mutations that cause hereditary cancer predisposing syndromes. 20% of patients have familial colorectal cancer (CRC), and about 30% of patients have tumors containing mutations that cause hereditary cancer predisposing syndromes.

References

1. Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. Early-onset colorectal cancer in young individuals. Mol Oncol. 2019 Feb;13(2):109-131. doi: 10.1002/1878-0261.12417. Epub 2018 Dec 22. PMID: 30520562; PMCID: PMC6360363.

2. Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):262-274. doi: 10.1016/S2468-1253(21)00426-X. Epub 2022 Jan 26. PMID: 35090605.

3. Eng C, Jácome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, Bailey C, Lieu CH. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 2022 Mar;23(3):e116-e128. doi: 10.1016/S1470-2045(21)00588-X. Epub 2022 Jan 31. PMID: 35090673.

4. Nfonsam V, Wusterbarth E, Gong A, Vij P. Early-Onset Colorectal Cancer. Surg Oncol Clin N Am. 2022 Apr;31(2):143-155. doi: 10.1016/j.soc.2021.11.001. Epub 2022 Mar 4. PMID: 35351270.

5. Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer. Gastroenterology. 2021 Mar;160(4):1041-1049. doi: 10.1053/j.gastro.2020.12.068. Epub 2021 Jan 5. PMID: 33417940; PMCID: PMC8273929.

6. REACCT Collaborative; Zaborowski AM, Abdile A, Adamina M, Aigner F, d'Allens L, Allmer C, et al. Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surg. 2021 Sep 1;156(9):865-874. doi: 10.1001/jamasurg.2021.2380. Erratum in: JAMA Surg. 2021 Sep 1;156(9):894. PMID: 34190968.

7. Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, Wu K, Cao Y, Ng K, Ogino S. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20. PMID: 33219329; PMCID: PMC7994182.

8. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1. PMID: 36856579.

9. Saraiva MR, Rosa I, Claro I. Early-onset colorectal cancer: A review of current knowledge. World J Gastroenterol. 2023 Feb 28;29(8):1289-1303. doi: 10.3748/wjg.v29.i8.1289. PMID: 36925459; PMCID: PMC10011966.

10. Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, Murphy EA, Sajish M, Sheth A, Buckhaults PJ, Berger FG. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):352-364. doi: 10.1038/s41575-019-0253-4. Epub 2020 Feb 21. Erratum in: Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):517. PMID: 32086499; PMCID: PMC10711686.

Downloads

Published

2024-11-29

How to Cite

Bagus, B. I. (2024). Increasing Incidence of Early Onset Locally Advanced Colorectal Cancer: Does Adjuvant Treatment Has a Clinical Improvement?. Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED), 2, 45–50. https://doi.org/10.29103/micohedmed.v2i.1203

Issue

Vol. 2 (2024): Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) 2024

Section

Articles

License

Copyright (c) 2024 Budhi Ida Bagus

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

n order for Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) to publish and disseminate research articles, we need non-exclusive publishing rights (transfered from author(s) to publisher). This is determined by a publishing agreement between the Author(s) and Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED). This agreement deals with the transfer or license of the copyright of publishing to Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED), while Authors still retain significant rights to use and share their own published articles. Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) supports the need for authors to share, disseminate and maximize the impact of their research and these rights, in any databases.

As a proceeding Author, you have rights for a large range of uses of your article, including use by your employing institute or company. These Author rights can be exercised without the need to obtain specific permission. Authors publishing in Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED) proceedings have wide rights to use their works for teaching and scholarly purposes without needing to seek permission, including:

  • use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees; 
  • use for internal training by author's company; 
  • distribution to colleagues for their reseearch use; 
  • use in a subsequent compilation of the author's works; 
  • inclusion in a thesis or dissertation; 
  • reuse of portions or extracts from the article in other works (with full acknowledgement of final article); 
  • preparation of derivative works (other than commercial purposes) (with full acknowledgement of final article); 
  • voluntary posting on open web sites operated by author or author’s institution for scholarly purposes, 

(but it should follow the open access license of Creative Common CC-by-SA License).

Authors/Readers/Third Parties can read, print and download, redistribute or republish the article (e.g. display in a repository), translate the article, download for text and data mining purposes, reuse portions or extracts from the article in other works, sell or re-use for commercial purposes, remix, transform, or build upon the material, they must distribute their contributions under the same license as the original Creative Commons Attribution-ShareAlike (CC BY-SA).